BiotechTube
Home/VenoStent/Mark Barakat, MD
MB

Mark Barakat, MD

VP of Clinical Affairs

VenoStent

Therapeutic Areas

CardiovascularNephrology

VenoStent Pipeline

DrugIndicationPhase
SelfWrapImprovement of arteriovenous (AV) access site maturation and patency for hemodialysisPivotal Trial

Leadership Team at VenoStent

TB
Tim Boire, PhD
CEO & Co-founder
GL
Geoff Lucks
COO & Co-founder
TM
Tina McArthur
VP of Research and Engineering
TB
Tim Barnett
VP of Quality Assurance
PM
Pamela Misajon
Chief Compliance Officer
View full VenoStent profile